Vikesh K. Singh, MD, MSc
Dr. Singh is currently an Associate Professor of Medicine in the Division of Gastroenterology at Johns Hopkins Hospital. He also serves as the Director of the Pancreatitis Center and the Medical Director of the Pancreatic Islet Autotransplantation Program. Dr. Singh was also recently appointed the Director of Endoscopy at Johns Hopkins Hospital in 2018. He is the Medical Director of the Mid-Atlantic Chapter of the National Pancreas Foundation. Dr. Singh’s research is focused on the medical as well as endoscopic diagnosis and treatment of inflammatory disorders of the pancreas. He is also interested in improving our understanding and management of patients with chronic abdominal pain due to both pancreatic and non-pancreatic conditions. He is also interested in the impact of genetic testing on the evaluation and management of patients with idiopathic pancreatitis. He has over 200 publications encompassing original scientific studies, review articles, book chapters, and consensus statements. He has served as a consultant and advisory board participant to several governmental organizations and industry.
Mary Felando, MS, RDN, FNLA
Mary Felando is a Registered Dietitian Nutritionist in the Los Angeles, Orange County and Palm Springs areas.
She received her Bachelor of Science Degree from the University of Maryland, completed her dietetic internship at Rhode Island Hospital and holds a Master of Science Degree in Human Nutrition from Cornell University. She began her nutrition career as a clinical dietitian at Mercy Hospital in Baltimore, Maryland. From 1986 to 2011, she worked as a cardiovascular dietitian for the Heart Institute at Cedars-Sinai Medical Center. Over the years, Mary has counseled more than 8000 patients with or at high risk for heart disease in individual, group and home sessions. Her specialization includes cardiac risk factor modification with lipid and weight management. In a 40-seat teaching kitchen, Mary taught heart healthy cooking classes. From 2012 to the present, Mary works as a nutrition consultant and a past employee for pharmaceutical companies specializing in rare lipid disorders, such as Homozygous Familial Hypercholesterolemia and Familial Chylomicronemia Syndrome.
Her professional activities include membership in the National Lipid Association, Academy of Nutrition and Dietetics, California Dietetic Association, Orange County Dietetic Association, and Cornell Alumni Association. She was awarded Diplomate status with the Accreditation Council for Clinical Lipidology and was on the board of the Pacific Lipid Association. From the American Dietetic Association, she holds Level One and Level Two Certificates in Adult Weight Management.
Ms. Felando is a frequent lecturer, both community and professional, and has spoken as a nutrition expert in newspapers, magazines, television, radio and on cruise ships. She enjoys her family and friends, cooking and collecting anything mid-century modern.
Zahid Ahmad, M.D
Zahid Ahmad, M.D., is an Assistant Professor in the Division of Endocrinology at UT Southwestern Medical Center.
Dr. Ahmad’s clinical and investigative focus is lipid metabolism disorders, including dyslipidemia, chylomicronemia, and familial hypercholesterolemia (FH).
His research aims to identify the causes of cholesterol and triglyceride disorders and to develop new treatment options for patients who suffer from them.Funded by the National Institutes of Health, Dr. Ahmad and his colleagues currently are working to identify families with these conditions in an effort to better understand their underlying genetic causes – and, ultimately, to improve patient outcomes.
Dr. Ahmad has published a number of scholarly articles and delivered many invited lectures.He joined the UT Southwestern faculty in 2010 and is American Board of Internal Medicine-certified in internal medicine, endocrinology, metabolism, and diabetes.
Dr. Ahmad earned his medical degree at the Tulane University School of Medicine.
He completed both a residency (internal medicine) and a fellowship (endocrinology and metabolism) at UT Southwestern Medical Center – training in cholesterol metabolism and genetics with mentors Drs. Abhimanyu Garg, Scott Grundy, and Helen Hobbs.
He also holds a B.S. in biomedical engineering from the Tulane University School of Engineering.
Paul D. Rosenblit, MD, PhD, FACE, FNLA, FASPC
Clinical Professor of Medicine
Dr. Paul Rosenblit is the Director and Principle Investigator of the Diabetes / Lipid Management and Research Center in Huntington Beach, California.
He is a Diplomate of the American Board of Endocrinology and Metabolism, has been in a private Clinical Practice setting for 30 years.
He is currently an endocrinology consultant, as an active medical staff member at Hoag Hospital, Newport Beach and a courtesy medical staff member at Huntington Beach Hospital, HB, Orange Coast Memorial Medical Center, Fountain Valley and St. Joseph’s Hospital, Orange, CA.
Dr. Rosenblit is a Clinical Professor of Medicine in the Division of Endocrinology, Diabetes, and Metabolism at the University of California, Irvine (UCI), School of Medicine, Irvine, California, and as volunteer clinical faculty, since 1990, is an attending, and Co-Director, of the Diabetes Out-Patient Clinic at the UCI Medical Center, Orange, California.
Since 1987, Dr. Rosenblit has served as the volunteer Endocrinology consultant for the Laguna Beach Community Clinic in Laguna Beach, California.
Dr. Rosenblit is a member of the American Association of Clinical Endocrinologists (AACE), a Fellow of the American College of Endocrinology and is currently serving on AACE education committees and task forces.
Dr. Rosenblit is a member of the Professional Sections of the American Diabetes Association and the Endocrine Society. He is a member of the Councils on Arteriosclerosis, Thrombosis & Vascular Biology and Clinical Cardiology, as a Silver Heart member of the American Heart Association.
Dr. Rosenblit is a member and Fellow of the National Lipid Association (NLA) and a Diplomate of the American Board of Clinical Lipidology. He is a founding member of the NLA-7-State Regional Pacific Lipid Association’s Board of Directors, and a Past-President.
Dr. Rosenblit is active, at his research site, as principal investigator on phase II & III pharmaceutical clinical trials in the disciplines of diabetes, obesity and lipids.
Dr. Rosenblit lectures as a disease state and promotional speaker faculty member of several pharmaceutical companies, and at various continuing medical education programs, with areas of interest including diabetology, clinical lipidology and cardiometabolic-cardiovascular disease.
Dr. Rosenblit has been Co-Director of the Annual Fall Orange County, CA, Symposium on Cardiovascular Disease Prevention.